Op-ed: Healthy habits are more important than ever – GREENVILLE JOURNAL – Greenville Journal

By Scot Baddley, president and CEO, YMCA of Greenville

My family and I have always been grateful for the gift of health. But the past year has made us cherish our health as a gift like we never have before.

What encourages me during the uncertain times were in is understanding the invaluable benefits of a healthy lifestyle. We can take proactive measures to defend our bodies from sickness like COVID-19 and other viruses. A recent study by the Henry Ford Health System shows that physically fit people are less likely to be hospitalized due to COVID-19. When you prioritize exercise, you are training your body not just to be strong, but also to fight disease, improve mental health and increase longevity.

Plus, by taking care of yourself, youre taking care of others, too your loved ones who depend on you and the people you meet in the community.

Exercise truly is medicine. Medical experts have cited the role an active lifestyle plays in reducing risk of developing common diseases.Mladen Golubic, M.D., Ph.D., reported that 80% of chronic diseases are driven by lifestyle factors. Just by maintaining a healthy weight, exercising regularly, following a healthy diet and not smoking, you are taking steps to save your own life. It is a simple formula, yet only one in three adults get the recommended amount of physical activity each week.

The key is to get started and make exercise a habit.

Stress is an epidemic. It lurks in the shadows of a much larger and more visible epidemic, but it remains a critical threat to mental health, which can have long-term effects.

Whether we realize it or not, stress takes a toll on us. From major life changes to daily micro-stresses, sustained stress can lead to a weakened immune system, high blood pressure, heart disease and more.

While we cannot always control circumstances, by exercising you can release stress and build a healthy routine to help you take on whatever your day brings you. Exercise makes me feel better about my day, and that carries into my work and family life.

Finally, exercise can help you live a longer life. One of our members at the George I. Theisen Family YMCA can speak to this. At 84 years old, she comes to the Y every day to ride 6 miles on the stationary bike. A picture of health with no signs of slowing down, she is a living testament to the fact that regular exercise keeps her vibrant and strong.

The hardest part of obtaining the gift of health, like anything worth taking on, is making the commitment. At an all-encompassing health center like the YMCA of Greenville, getting started and making the commitment is as simple as making the decision to walk through the door and keep coming back. The Y welcomes everyone, at any stage of their life and at any stage of their health journey.

The Y meets you where you are, providing you with the encouragement, accountability and tools to be successful. When you keep coming back, you keep giving yourself and your family the gift of health.

View post:
Op-ed: Healthy habits are more important than ever - GREENVILLE JOURNAL - Greenville Journal

ReGen Scientific First Health Institute in Canada to Introduce Evry into Proactive Brain Health Management and COVID-19 ‘Long-Hauler’ Research and…

TORONTO, Feb. 10, 2021 (GLOBE NEWSWIRE) -- ReGen Scientific, a leader in personalized, preventative, and regenerative health announced today it will become the first comprehensive health clinic in Canada to bringSynaptive Medicals Evry, a superconducting 0.5T head magnetic resonance imaging (MRI) system intended to provide MRI directly at the point-of-care, to their downtown Toronto location.

Maintaining a healthy brain during ones life is the uppermost goal in pursuing health and longevity, said Dr. Robert Francis, chairman and co-founder of ReGen Scientific. The information and images provided by Evry will inform and support our team of medical professionals in developing personalized proactive strategies to maintain and or restore brain health and cognitive performance to improve quality of life.

At the heart of ReGen Scientifics mission is to change the way health is measured and care is delivered with a hyper-personalized approach to health and wellness. With ReGen Scientifics adoption of Evry, for the first time ever, high performance MRI technology will become accessible directly at a patients point of care within a health clinic, giving doctors vital and potentially life-saving information when and where they need it most, said Cameron Piron, president and co-founder of Synaptive Medical. Our team spent years developing Evry and we are excited to partner with an already established Canadian leader in preventative health, ReGen Scientific, to bring this technology to Canadians seeking to understand the health of their brain well before issues arise.

Evry, which received Health Canada approval in February 2020 and FDA clearance in April of 2020, is currently being used in connection with multiple research studies being done at the QEII Health Sciences Centre in Halifax, Nova Scotia including neuroimaging of stroke and tumor patients, with research funding also having been received to assess and track the impact that COVID-19 may have on the brain.

There are increasing scientific studies revealing that recovery from COVID-19 is a long-haul, meaning survivors continue to suffer debilitating illness and symptoms months after having it. This has created a COVID-19 long-haulers global patient movement seeking help with understanding what has happened within their bodies.

Jean-Marc MacKenzie, CEO and co-founder of ReGen Scientific indicated, ReGen Scientific is looking forward to supporting critical medical research on COVID-19 long-haulers, but more importantly, working to identify treatments that will assist individuals overcome with any lingering effects of COVID-19.

About ReGen Scientific Inc.

ReGen Scientific, is a Toronto based leader in personalized, preventative, and regenerative health. It is accelerating the loop between discovery medical science and evolutions in clinical and functional medicine. ReGen delivers hyper-personalized care based on its Science of You, which enables individuals to take control of their health with an objective of not only extending years lived but the ability to live those years with vitality and health. ReGen Scientific will launch its much-anticipated Toronto based Health Institute, in April 2021. This medical campus will offer the latest in health informatics, genetic testing, predictive screening, regenerative treatments, therapeutics, anti-aging research and functional medicine.

About Synaptive Medical

Synaptive Medical Inc., a Toronto-based, global medical device and technology company solves surgical, imaging, and data challenges to improve the quality of human lives. Synaptives integrated suite of products bridging MRI, surgical planning, navigation, and robotic visualization delivers novel information with automated efficiency across all stages of clinical intervention.

Media Contact

Rob FrancisChief Operating OfficerReGen Scientific 416-704-3064rob@regen.care

Katrina FerroSenior Marketing Associate, Events and CommunicationsSynaptive Medical 647-243-3355katrina.ferro@synaptivemedical.com

Read more here:
ReGen Scientific First Health Institute in Canada to Introduce Evry into Proactive Brain Health Management and COVID-19 'Long-Hauler' Research and...

Outlook on the CRISPR Gene Editing Global Market to 2030 – Analysis and Forecasts – Yahoo Finance

Dublin, Feb. 08, 2021 (GLOBE NEWSWIRE) -- The "Global CRISPR Gene Editing Market: Focus on Products, Applications, End Users, Country Data (16 Countries), and Competitive Landscape - Analysis and Forecast, 2020-2030" report has been added to ResearchAndMarkets.com's offering.

The global CRISPR gene editing market was valued at $846.2 million in 2019 and is expected to reach $10,825.1 million by 2030, registering a CAGR of 26.86% during the forecast.

The development of genome engineering with potential applications proved to reflect a remarkable impact on the future of the healthcare and life science industry. The high efficiency of the CRISPR-Cas9 system has been demonstrated in various studies for genome editing, which resulted in significant investments within the field of genome engineering. However, there are several limitations, which need consideration before clinical applications. Further, many researchers are working on the limitations of CRISPR gene editing technology for better results. The potential of CRISPR gene editing to alter the human genome and modify the disease conditions is incredible but exists with ethical and social concerns.

The growth is attributed to the increasing demand in the food industry for better products with improved quality and nutrient enrichment and the pharmaceutical industry for targeted treatment for various diseases. Further, the continued significant investments by healthcare companies to meet the industry demand and growing prominence for the gene therapy procedures with less turnaround time are the prominent factors propelling the growth of the global CRISPR gene editing market.

Research organizations, pharmaceutical and biotechnology industries, and institutes are looking for more efficient genome editing technologies to increase the specificity and cost-effectiveness, also to reduce turnaround time and human errors. Further, the evolution of genome editing technologies has enabled wide range of applications in various fields, such as industrial biotech and agricultural research. These advanced methods are simple, super-efficient, cost-effective, provide multiplexing, and high throughput capabilities. The increase in the geriatric population and increasing number of cancer cases, and genetic disorders across the globe are expected to translate into significantly higher demand for CRISPR gene editing market.

Story continues

Furthermore, the companies are investing huge amounts in the research and development of CRISPR gene editing products, and gene therapies. The clinical trial landscape of various genetic and chronic diseases has been on the rise in recent years, and this will fuel the CRISPR gene editing market in the future.

Within the research report, the market is segmented based on product type, application, end-user, and region. Each of these segments covers the snapshot of the market over the projected years, the inclination of the market revenue, underlying patterns, and trends by using analytics on the primary and secondary data obtained.

Key Companies Profiled

Abcam, Inc., Applied StemCell, Inc., Agilent Technologies, Inc., Cellecta, Inc., CRISPR Therapeutics AG, Thermo Fisher Scientific, Inc., GeneCopoeia, Inc., GeneScript Biotech Corporation, Horizon Discovery Group PLC, Integrated DNA Technologies, Inc., Merck KGaA, New England Biolabs, Inc., Origene Technologies, Inc., Rockland Immunochemicals, Inc., Synthego Corporation, System Biosciences LLC, ToolGen, Inc., Takara Bio

Key Questions Answered in this Report:

What is CRISPR gene editing?

What is the timeline for the development of CRISPR technology?

How did the CRISPR gene editing market evolve, and what is its scope in the future?

What are the major market drivers, restraints, and opportunities in the global CRISPR gene editing market?

What are the key developmental strategies that are being implemented by the key players to sustain this market?

What is the patent landscape of this market? What will be the impact of patent expiry on this market?

What is the impact of COVID-19 on this market?

What are the guidelines implemented by different government bodies to regulate the approval of CRISPR products/therapies?

How is CRISPR gene editing being utilized for the development of therapeutics?

How will the investments by public and private companies and government organizations affect the global CRISPR gene editing market?

What was the market size of the leading segments and sub-segments of the global CRISPR gene editing market in 2019?

How will the industry evolve during the forecast period 2020-2030?

What will be the growth rate of the CRISPR gene editing market during the forecast period?

How will each of the segments of the global CRISPR gene editing market grow during the forecast period, and what will be the revenue generated by each of the segments by the end of 2030?

Which product segment and application segment are expected to register the highest CAGR for the global CRISPR gene editing market?

What are the major benefits of the implementation of CRISPR gene editing in different field of applications including biomedical research, agricultural research, industrial research, gene therapy, drug discovery, and diagnostics?

What is the market size of the CRISPR gene editing market in different countries of the world?

Which geographical region is expected to contribute to the highest sales of CRISPR gene editing market?

What are the reimbursement scenario and regulatory structure for the CRISPR gene editing market in different regions?

What are the key strategies incorporated by the players of global CRISPR gene editing market to sustain the competition and retain their supremacy?

Key Topics Covered:

1 Technology Definition

2 Research Scope

3 Research Methodology

4 Market Overview4.1 Introduction4.2 CRISPR Gene Editing Market Approach4.3 Milestones in CRISPR Gene Editing4.4 CRISPR Gene Editing: Delivery Systems4.5 CRISPR Technology: A Potential Tool for Gene Editing4.6 CRISPR Gene Editing Current Scenario4.7 CRISPR Gene Editing Market: Future Potential Application Areas

5 Global CRISPR Gene Editing Market, $Million, 2020-20305.1 Pipeline Analysis5.2 CRISPR Gene Editing Market and Growth Potential, 2020-20305.3 Impact of COVID-19 on CRISPR Gene Editing Market5.3.1 Impact of COVID-19 on Global CRISPR Gene Editing Market Growth Rate5.3.1. Impact on CRISPR Gene Editing Companies5.3.2 Clinical Trial Disruptions and Resumptions5.3.3 Application of CRISPR Gene Editing in COVID-19

6 Market Dynamics6.1 Impact Analysis6.2 Market Drivers6.2.1 Prevalence of Genetic Disorders and Use of Genome Editing6.2.2 Government and Private Funding6.2.3 Technology Advancement in CRISPR Gene Editing6.3 Market Restraints6.3.1 CRISPR Gene Editing: Off Target Effects and Delivery6.3.2 Ethical Concerns and Implications With Respect to Human Genome Editing6.4 Market Opportunities6.4.1 Expanding Gene and Cell Therapy Area6.4.2 CRISPR Gene Editing Scope in Agriculture

7 Industry Insights7.1 Introduction7.2 Funding Scenario7.3 Regulatory Scenario of CRISPR Gene Editing Market7.4 Pricing of CRISPR Gene Editing7.5 Reimbursement of CRISPR Gene Editing7.5.1 CRISPR Gene Editing: Insurance Coverage in the U.S.

8 CRISPR Gene Editing Patent Landscape8.1 Overview8.2 CRISPR Gene Editing Market Patent Landscape: By Application8.3 CRISPR Gene Editing Market Patent Landscape: By Region8.4 CRISPR Gene Editing Market Patent Landscape: By Year

9 Global CRISPR Gene Editing Market (by Product Type), $Million9.1 Overview9.2 CRISPR Products9.2.1 Kits and Enzymes9.2.1.1 Vector-Based Cas99.2.1.2 DNA-Free Cas99.2.2 Libraries9.2.3 Design Tools9.2.4 Antibodies9.2.5 Other Products9.3 CRISPR Services9.3.1 gRNA Design and Vector Construction9.3.2 Cell Line and Engineering9.3.3 Screening Services9.3.4 Other Services

10 CRISPR Gene Editing Market (by Application), $Million10.1 Overview10.2 Agriculture10.3 Biom
edical10.3.1 Gene Therapy10.3.2 Drug Discovery10.3.3 Diagnostics10.4 Industrial10.5 Other Applications

11 Global CRISPR Gene Editing Market (by End User)11.1 Academic Institutions and Research Centers11.2 Biotechnology Companies11.3 Contract Research Organizations (CROs)11.4 Pharmaceutical and Biopharmaceutical Companies

12 Global CRISPR Gene Editing Market (by Region)12.1 Introduction12.2 North America12.3 Europe12.4 Asia-Pacific12.5 Latin America

13 Competitive Landscape13.1 Key Developments and Strategies13.1.1 Overview13.1.1.1 Regulatory and Legal Developments13.1.1.2 Synergistic Activities13.1.1.3 M&A Activities13.1.1.4 Funding Activities13.2 Market Share Analysis13.3 Growth Share Analysis

14 Company Profiles14.1 Overview14.2 Abcam, Inc.14.2.1 Company Overview14.2.2 Role of Abcam, Inc. in the Global CRISPR Gene Editing Market14.2.3 Financials14.2.4 SWOT Analysis14.3 Applied StemCell, Inc.14.3.1 Company Overview14.3.2 Role of Applied StemCell, Inc. in the Global CRISPR Gene Editing Market14.3.3 SWOT Analysis14.4 Agilent Technologies, Inc.14.4.1 Company Overview14.4.2 Role of Agilent Technologies, Inc. in the Global CRISPR Gene Editing Market14.4.3 Financials14.4.4 R&D Expenditure, 2017-201914.4.5 SWOT Analysis14.5 Cellecta, Inc.14.5.1 Company Overview14.5.2 Role of Cellecta, Inc. in the Global CRISPR Gene Editing Market14.5.3 SWOT Analysis14.6 CRISPR Therapeutics AG14.6.1 Company Overview14.6.2 Role of CRISPR Therapeutics AG in the Global CRISPR Gene Editing Market14.6.3 Financials14.6.4 R&D Expenditure, 2017-201914.6.5 SWOT Analysis14.7 Thermo Fisher Scientific, Inc. INC14.7.1 Company Overview14.7.2 Role of Thermo Fisher Scientific, Inc. in the Global CRISPR Gene Editing Market14.7.3 Financials14.7.4 R&D Expenditure, 2017-201914.7.5 SWOT Analysis14.8 GeneCopoeia, Inc.14.8.1 Company Overview14.8.2 Role of GeneCopoeia, Inc. in the Global CRISPR Gene Editing Market14.8.3 SWOT Analysis14.9 GeneScript Biotech Corporation14.9.1 Company Overview14.9.2 Role of GenScript Biotech in the Global CRISPR Gene Editing Market14.9.3 Financials14.9.4 SWOT Analysis14.1 Horizon Discovery Group PLC14.10.1 Company Overview14.10.2 Role of Horizon Discovery Group PLC in the Global CRISPR Gene Editing Market14.10.3 Financials14.10.4 SWOT Analysis14.11 Integrated DNA Technologies, Inc.14.11.1 Company Overview14.11.2 Role of Integrated DNA Technologies, Inc. in the Global CRISPR Gene Editing Market14.11.3 SWOT Analysis14.12 Merck KGaA14.12.1 Company Overview14.12.2 Role of Merck KGaA in the Global CRISPR Gene Editing Market14.12.3 Financials14.12.4 SWOT Analysis14.13 New England Biolabs, Inc.14.13.1 Company Overview14.13.2 Role of Integrated DNA Technologies, Inc. in the Global CRISPR Gene Editing Market14.13.3 SWOT Analysis14.14 Origene Technologies, Inc.14.14.1 Company Overview14.14.2 Role of Origene Technologies, Inc. in the Global CRISPR Gene Editing Market14.14.3 SWOT Analysis14.15 Rockland Immunochemicals, Inc.14.15.1 Company Overview14.15.2 Role of Rockland Immunochemicals, Inc. in the Global CRISPR Gene Editing Market14.15.3 SWOT Analysis14.16 Synthego Corporation14.16.1 Company Overview14.16.2 Role of Synthego Corporation in the Global CRISPR Gene Editing Market14.16.3 SWOT Analysis14.17 System Biosciences LLC14.17.1 Company Overview14.17.2 Role of System Biosciences LLC in the Global CRISPR Gene Editing Market14.17.3 SWOT Analysis14.18 ToolGen, Inc.14.18.1 Company Overview14.18.2 Role of ToolGen, Inc. in the Global CRISPR Gene Editing Market14.18.3 SWOT Analysis14.19 Takara Bio14.19.1 Company Overview14.19.2 Role of Takara Bio in the Global CRISPR Gene Editing Market14.19.3 Financials14.19.4 SWOT Analysis

For more information about this report visit https://www.researchandmarkets.com/r/c7om7t

Go here to see the original:
Outlook on the CRISPR Gene Editing Global Market to 2030 - Analysis and Forecasts - Yahoo Finance

Global CRISPR Gene Editing Market (2020 to 2030) – Focus on Products, Applications, End-users, Country Data and Competitive Landscape -…

DUBLIN--(BUSINESS WIRE)--The "Global CRISPR Gene Editing Market: Focus on Products, Applications, End Users, Country Data (16 Countries), and Competitive Landscape - Analysis and Forecast, 2020-2030" report has been added to ResearchAndMarkets.com's offering.

The global CRISPR gene editing market was valued at $846.2 million in 2019 and is expected to reach $10,825.1 million by 2030, registering a CAGR of 26.86% during the forecast.

The development of genome engineering with potential applications proved to reflect a remarkable impact on the future of the healthcare and life science industry. The high efficiency of the CRISPR-Cas9 system has been demonstrated in various studies for genome editing, which resulted in significant investments within the field of genome engineering. However, there are several limitations, which need consideration before clinical applications. Further, many researchers are working on the limitations of CRISPR gene editing technology for better results. The potential of CRISPR gene editing to alter the human genome and modify the disease conditions is incredible but exists with ethical and social concerns.

The growth is attributed to the increasing demand in the food industry for better products with improved quality and nutrient enrichment and the pharmaceutical industry for targeted treatment for various diseases. Further, the continued significant investments by healthcare companies to meet the industry demand and growing prominence for the gene therapy procedures with less turnaround time are the prominent factors propelling the growth of the global CRISPR gene editing market.

Research organizations, pharmaceutical and biotechnology industries, and institutes are looking for more efficient genome editing technologies to increase the specificity and cost-effectiveness, also to reduce turnaround time and human errors. Further, the evolution of genome editing technologies has enabled wide range of applications in various fields, such as industrial biotech and agricultural research. These advanced methods are simple, super-efficient, cost-effective, provide multiplexing, and high throughput capabilities. The increase in the geriatric population and increasing number of cancer cases, and genetic disorders across the globe are expected to translate into significantly higher demand for CRISPR gene editing market.

Furthermore, the companies are investing huge amounts in the research and development of CRISPR gene editing products, and gene therapies. The clinical trial landscape of various genetic and chronic diseases has been on the rise in recent years, and this will fuel the CRISPR gene editing market in the future.

Within the research report, the market is segmented based on product type, application, end-user, and region. Each of these segments covers the snapshot of the market over the projected years, the inclination of the market revenue, underlying patterns, and trends by using analytics on the primary and secondary data obtained.

Key Questions Answered in this Report:

Market Dynamics

Growth Drivers

Restraints

Opportunities

Companies Mentioned

For more information about this report visit https://www.researchandmarkets.com/r/rky1va

See the original post here:
Global CRISPR Gene Editing Market (2020 to 2030) - Focus on Products, Applications, End-users, Country Data and Competitive Landscape -...

Geoengineering: What could possibly go wrong? Elizabeth Kolbert’s take, in her new book – Bulletin of the Atomic Scientists

Editors note: This story was originally published by Grist. It appears here as part of theClimate Deskcollaboration. Elizabeth Kolbert is a former member of the Science and Security Board of the Bulletin of the Atomic Scientists.

In Australia, scientists collect buckets of coral sperm, mixing one species with another in an attempt to create a new super coral that can withstand rising temperatures and acidifying seas. In Nevada, scientists nurse a tiny colony of one-inch long Devils Hole pupfish in an uncomfortably hot, Styrofoam-molded pool. And in Massachusetts, Harvard University scientists research injecting chemicals into the atmosphere to dim the suns lightand slow down the runaway pace of global warming.

These are some of the scenes from Elizabeth Kolberts new book,Under a White Sky, a global exploration of the ways that humanity is attempting to engineer, fix, or reroute the course of nature in a climate-changed world. (The title refers to one of the consequences of engineering the Earth to better reflect sunlight: Our usual blue sky could turn apale white.)

Kolbert, a New Yorker staff writer, has been covering the environment for decades: Her first book,Field Notes from a Catastrophe, traced the scientific evidence for global warming from Greenland to Alaska; her second,The Sixth Extinction, followed the growing pace of animal extinctions.

Under a White Skycovers slightly different ground. Humanity is now, Kolbert explains, in the midst of the Anthropocenea geologic era in whichweare the dominant force shaping earth, sea, and sky. Faced with that reality, humans have gotten more creative at using technology to fix the problems that we unwittingly spawned: Stamping out Australias cane toad invasion with genetic engineering, for example, or using giant air conditioners to suck carbon dioxide out of air and turn it into rock. As Kolbert notes, tongue-in-cheek: What could possibly go wrong?

This interview has been condensed and lightly edited for clarity.

Osaka:Under a White Skyis about a lot of things rivers, solar geoengineering, coral reefs but its also about what nature means in our current world. What got you interested in that topic?

Kolbert: All books have complicated births, as it were. But about four years ago, I went to Hawaii to report on a project that had been nicknamed the super coral project. And it was run by a very charismatic scientist namedRuth Gates, who very sadly passed away about two years ago. We have very radically altered the oceans by pouring hundreds of billions of tons of carbon dioxide into the airand we cant get that heat out of the oceans in any foreseeable timescale. We cant change the chemistry back. And if we want coral reefs in the future, were going to have to counter what weve done to the oceans by remaking reefs so they can withstand warmer temperatures. The aim of the project was to see if you could hybridize or crossbreed corals to get more vigorous varieties.

This ideathat we have to counteract one form of intervention in the natural world (climate change) with another form of intervention (trying to recreate reefs)just struck me as a very interesting new chapter in our long and very complicated relationship with nature. And once I started to think about it that way, I started to see that as a pretty widespread pattern. Thats really what prompted the book.

Osaka: Some of these human interventions to save nature seem hopeful and positiveand others go wrong in pretty epic ways. How do you balance those two types of stories?

Kolbert: The book starts with examples that probably will strike many readers as Okay, that makes sense. That makes sense. But it goes from regional engineering solutions through biotechnology, through gene editing, and all the way up to solar geoengineering. So it kind of leads you down what we might call a slippery slope. And one of the interesting things about these cases is that they will divide up people differently. Even people who consider themselves environmentalists will come down on different sides of some of these technologies. The bind were in is so profound that theres no right answer.

Osaka: So someone who accepts what were doing to save the Devils Hole pupfish might not necessarily accept gene-editing mosquitos or dimming the sun through solar geoengineering.

Kolbert: Exactly. And I think sometimes those linesseemclearer than they are once you start to think about it.

Osaka: At one point in the book, theres a quote that is (apocryphally) attributed to Einstein: We cannot solve our problems with the same thinking we used when we created them. But you dont say whether you agree with that sentiment or not. Is that on purpose?

Kolbert: Yeah, you can read the book and say, Im really glad people are doing these things, and I feel better. Or you can read the book and say, as one scientific quote does, This is a broad highway to hell. And both of those are very valid reactions.

Osaka: When you write about geoengineering, you point out that many scientists conclude that its necessary to avoid catastrophic levels of warming, but that it could also be a really bad ideKolbert Do you think that in 15 or 20 years youll be writing about a geoengineering experiment gone wrong, much as youre writing now about failed attempts to protect Louisiana from flooding?

Kolbert: I might argue about the timescales. Im not sure Ill be reporting on it in 15 years, but I thinkyoumight be reporting on it in 30 years.

At the moment, its still the realm of sci-fi, and Im not claiming to have any particular insight into how people are going to respond in the future. But the case thats made in the book by some very smart scientists is that we dont have very many tools in our toolbox for dealing with climate change quickly, because the system has so much inertia. Its like turning around a supertanker: It takes literally decades, even if we do everything absolutely right.

Osaka: Youve reported on climate change for a long time. How does it feel to see geoengineering being explored as a more valuableand potentially necessaryoption?

Kolbert: Well, one thing I learned in the course of reporting the book was that what we now refer to as geoengineering was actually the very first thing that people started to think about when they first realized we were warming the climate. The very first report about climate change that was handed to Lyndon Johnson in 1965 wasnt about how we should stop emittingit was: Maybe we should find some reflective stuff to throw into the ocean to bounce more sunlight back into space!

Its odd, its kind of almost freakish, and I cant explain it, except to say that it sort of fits the pattern of the book.

Osaka: Theres been a longstanding fight in environmentalism between a technology-will-save-us philosophy and a return-to-nature philosophy. Based on the reporting in this book, do you think that the technology camp has won?

Kolbert: I think the book is an attempt to take on both of those schools of thought. On some level, technologyhaswoneven people who would say dont do geoengineering still want to put up solar panels and build huge arrays of batteries, and those are technologies! But where does that leave us? It goes back to Ruth Gates and the super coral project. There was a big fight among coral biologists about whether a project like that should even be pursued. The Great Barrier Reef is the size of Italyeven if you have some replacement coral, how are you going to get them out on the reef? But Gatess point was, were not returning. Even if we stopped emitting carbon dioxide tomorrow, youre not getting the Great Barrier Reef back as it was in a foreseeable timeframe.

My impulse as an old-school environmentalist is to say Well, lets just leave things alone. But the sad fact is that weve intervened so much at this point that evennot intervening is itself an intervention.

Osaka: Now that we have a US president who takes climate change seriously, do you think we could actually start cutting carbon em
issions quickly

Kolbert: I really do want to applaud the first steps that theBiden administration has taken. I think they show a pretty profound understanding of the problem. But the question, and its a big one, is What are the limits? Will Congress do anything? What will happen in theSupreme Court? The United States is no longer the biggest emitter on an annual basis, but on a cumulative basis were still the biggest. And we still dont have resolution on how much carbon dioxdie we can put up there to avoid 1.5 or 2 degrees Celsius (3.6 degrees Fahrenheit) of warming. Those are questions with big error bars. If were lucky, I think we can avoid disastrous climate change. But if were not lucky, were already in deep trouble.

Osaka: Is there anything else you want to say about the book?

Kolbert: It sounds kind of weird after our conversation, but the book was actually a lot of fun to write. It sounds odd when youre talking about a book where the subject is so immensely serious.

Osaka: You mean like when the undergraduates in Australia are tossing each other buckets of coral sperm?

Kolbert: Yes! There is always humor in all these situations. I hope that sense of fun comes through.

See more here:
Geoengineering: What could possibly go wrong? Elizabeth Kolbert's take, in her new book - Bulletin of the Atomic Scientists

Interview: Elizabeth Kolbert on why well never stop messing with nature – Grist

In Australia, scientists collect buckets of coral sperm, mixing one species with another in an attempt to create a new super coral that can withstand rising temperatures and acidifying seas. In Nevada, scientists nurse a tiny colony of one-inch long Devils Hole pupfish in an uncomfortably hot, Styrofoam-molded pool. And in Massachusetts, Harvard University scientists research injecting chemicals into the atmosphere to dim the suns light and slow down the runaway pace of global warming.

These are some of the scenes from Elizabeth Kolberts new book, Under a White Sky, a global exploration of the ways that humanity is attempting to engineer, fix, or reroute the course of nature in a climate-changed world. (The title refers to one of the consequences of engineering the Earth to better reflect sunlight: Our usual blue sky could turn a pale white.)

Kolbert, a New Yorker staff writer, has been covering the environment for decades: Her first book, Field Notes from a Catastrophe, traced the scientific evidence for global warming from Greenland to Alaska; her second, The Sixth Extinction, followed the growing pace of animal extinctions.

Under a White Sky covers slightly different ground. Humanity is now, Kolbert explains, in the midst of the Anthropocene a geologic era in which we are the dominant force shaping earth, sea, and sky. Faced with that reality, humans have gotten more creative at using technology to fix the problems that we unwittingly spawned: Stamping out Australias cane toad invasion with genetic engineering, for example, or using giant air conditioners to suck carbon dioxide out of air and turn it into rock. As Kolbert notes, tongue-in-cheek: What could possibly go wrong?

This interview has been condensed and lightly edited for clarity.

Q.Under a White Sky is about a lot of things rivers, solar geoengineering, coral reefs but its also about what nature means in our current world. What got you interested in that topic?

A.All books have complicated births, as it were. But about four years ago, I went to Hawaii to report on a project that had been nicknamed the super coral project. And it was run by a very charismatic scientist named Ruth Gates, who very sadly passed away about two years ago. We have very radically altered the oceans by pouring hundreds of billions of tons of CO2 into the air and we cant get that heat out of the oceans in any foreseeable timescale. We cant change the chemistry back. And if we want coral reefs in the future, were going to have to counter what weve done to the oceans by remaking reefs so they can withstand warmer temperatures. The aim of the project was to see if you could hybridize or crossbreed corals to get more vigorous varieties.

This idea that we have to counteract one form of intervention in the natural world (climate change) with another form of intervention (trying to recreate reefs) just struck me as a very interesting new chapter in our long and very complicated relationship with nature. And once I started to think about it that way, I started to see that as a pretty widespread pattern. Thats really what prompted the book.

Q.Some of these human interventions to save nature seem hopeful and positive and others go wrong in pretty epic ways. How do you balance those two types of stories?

A.The book starts with examples that probably will strike many Grist readers as OK, that makes sense. That makes sense. But it goes from regional engineering solutions through biotechnology, through gene editing, and all the way up to solar geoengineering. So it kind of leads you down what we might call a slippery slope. And one of the interesting things about these cases is that they will divide up people differently. Even people who consider themselves environmentalists will come down on different sides of some of these technologies. The bind were in is so profound that theres no right answer.

Q.So someone who accepts what were doing to save the Devils Hole pupfish might not necessarily accept gene-editing mosquitos or dimming the sun through solar geoengineering.

A.Exactly. And I think sometimes those lines seem clearer than they are once you start to think about it.

Q.At one point in the book, theres a quote that is (apocryphally) attributed to Einstein: We cannot solve our problems with the same thinking we used when we created them. But you dont say whether you agree with that sentiment or not. Is that on purpose?

A.Yeah, you can read the book and say, Im really glad people are doing these things, and I feel better. Or you can read the book and say, as one scientific quote does, This is a broad highway to hell. And both of those are very valid reactions.

Q.When you write about geoengineering, you point out that many scientists conclude that its necessary to avoid catastrophic levels of warming, but that it could also be a really bad idea. Do you think that in 15 or 20 years youll be writing about a geoengineering experiment gone wrong, much as youre writing now about failed attempts to protect Louisiana from flooding?

A.I might argue about the timescales. Im not sure Ill be reporting on it in 15 years, but I think you might be reporting on it in 30 years.

At the moment, its still the realm of sci-fi, and Im not claiming to have any particular insight into how people are going to respond in the future. But the case thats made in the book by some very smart scientists is that we dont have very many tools in our toolbox for dealing with climate change quickly, because the system has so much inertia. Its like turning around a supertanker: It takes literally decades, even if we do everything absolutely right.

Q.Youve reported on climate change for a long time. How does it feel to see geoengineering being explored as a more valuable and potentially necessary option?

A.Well, one thing I learned in the course of reporting the book was that what we now refer to as geoengineering was actually the very first thing that people started to think about when they realized we were warming the climate. The very first report about climate change that was handed to Lyndon Johnson in 1965 wasnt about how we should stop emitting it was: Maybe we should find some reflective stuff to throw into the ocean to bounce more sunlight back into space!

Its odd, its kind of almost freakish, and I cant explain it, except to say that it sort of fits the pattern of the book.

Q.Theres been a longstanding fight in environmentalism between a technology-will-save-us philosophy and a return-to-nature philosophy. Based on the reporting in this book, do you think that the technology camp has won?

A.I think the book is an attempt to take on both of those schools of thought. On some level, technology has won even people who would say dont do geoengineering still want to put up solar panels and build huge arrays of batteries, and those are technologies! But where does that leave us? It goes back to Ruth Gates and the super coral project. There was a big fight among coral biologists about whether a project like that should even be pursued. The Great Barrier Reef is the size of Italy even if you have some replacement coral, how are you going to get them out on the reef? But Gatess point was, were not returning. Even if we stopped emitting CO2 tomorrow, youre not getting the Great Barrier Reef back as it was in a foreseeable timeframe.

My impulse as an old-school environmentalist is to say Well, lets just leave things alone. But the sad fact is that weve intervened so much at this point that even not intervening is itself an intervention.

Q.Now that we have a U.S. president who takes climate change seriously, do you think we could actually start cutting carbon emissions quickly?

A.I really do want to applaud the first steps that the Biden administration has taken. I think they show a pretty profound understanding of the problem. But the question, and its a big one, is What are the limits? Will Congress do anything? What will happen in the Supreme Court? The U.S. i
s no longer the biggest emitter on an annual basis, but on a cumulative basis were still the biggest. And we still dont have resolution on how much CO2 we can put up there to avoid 1.5 or 2 degrees Celsius of warming. Those are questions with big error bars. If were lucky, I think we can avoid disastrous climate change. But if were not lucky, were already in deep trouble.

Q.Is there anything else you want to say about the book?

A.It sounds kind of weird after our conversation, but the book was actually a lot of fun to write. It sounds odd when youre talking about a book where the subject is so immensely serious.

Q.You mean like when the undergraduates in Australia are tossing each other buckets of coral sperm?

A.Yes! There is always humor in all these situations. I hope that sense of fun comes through.

Will Biden deliver on climate? Get weekly analysis of federal climate policy action in the first months of Bidens term.

Here is the original post:
Interview: Elizabeth Kolbert on why well never stop messing with nature - Grist

An Introduction to PCR – Technology Networks

Polymerase chain reaction (PCR) is a technique that has revolutionized the world of molecular biology and beyond. In this article, we will discuss a brief history of PCR and its principles, highlighting the different types of PCR and the specific purposes to which they are being applied.

In 1983, American biochemist Kary Mullis was driving home late at night when a flash of inspiration struck him. He wrote on the back of a receipt the idea that would eventually grant him the Nobel Prize for Chemistry in 1993. The concept was straightforward: reproducing in a laboratory tube the DNA replication process that takes place in cells. The outcome is the same: the generation of new complementary DNA (cDNA) strands based upon the existing ones.

Mullis used the basis of Sanger's DNA sequencing as a starting point for his new technique. He realized that the repeated use of DNA polymerase triggered a chain reaction resulting in a specific DNA segment's amplification.

The foundations for his idea were laid by a discovery in 1976 of a thermostable DNA polymerase, Taq, isolated from the bacterium Thermus aquaticus found in hot springs.1 Taq DNA polymerase has a temperature optimum of 72 C and survives prolonged exposure to temperatures as high as 96 C, meaning that it can tolerate several denaturation cycles.

Before the discovery of Taq polymerase, molecular biologists were already trying to optimize cyclic DNA amplification protocols, but they needed to add fresh polymerase at each cycle because the enzyme could not withstand the high temperatures needed for DNA denaturation. Having a thermostable enzyme meant that they could repeat the amplification process many times over without the need for fresh polymerase at every cycle, making the whole process scalable, more efficient and less time-consuming.

The first description of this polymerase chain reaction (PCR) using Taq polymerase was published in Science in 1985.2

In 1993, the first FDA-approved PCR kit came to market. Since then, PCR has been steadily and systematically improved. It has become a game-changer in everything from forensic evidence analysis and diagnostics, to disease monitoring and genetic engineering. It is undoubtedly considered one of the most important scientific advances of the 20th century.

The PCR is used to amplify a specific DNA fragment from a complex mixture of starting material called template DNA. The sample preparation and purification protocols depend on the starting material, including the sample matrix and accessibility of target DNA. Often, minimal DNA purification is needed. However, PCR does require knowledge of the DNA sequence information that flanks the DNA fragment to be amplified (called target DNA).

From a practical point of view, a PCR experiment is relatively straightforward and can be completed in a few hours. In general, a PCR reaction needs five key reagents:

DNA to be amplified: also called PCR template or template DNA. This DNA can be of any source, such as genomic DNA (gDNA), cDNA, and plasmid DNA.DNA polymerase: all PCR reactions require a DNA polymerase that can work at high temperatures. Taq polymerase is a commonly used one, which can incorporate nucleotides at a rate of 60 bases/second at 70 C and can amplify templates of up to 5 kb, making it suitable for standard PCR without special requirements. New generations of polymerases are being engineered to improve reaction performance. For example, some are engineered to be only activated at high temperatures to reduce non-specific amplification at the beginning of the reaction. Others incorporate a proofreading function, important, for example, when it is critical that the amplified sequence matches the template sequence exactly, such as during cloning.Primers: DNA polymerases require a short sequence of nucleotides to indicate where they need to initiate amplification. In a PCR, these sequences are called primers and are short pieces of single-stranded DNA (approximately 15-30 bases). When designing a PCR experiment, the researcher determines the region of DNA to be amplified and designs a pair of primers, one on the forward strand and one on the reverse, that specifically flanks the target region. Primer design is a key component of a PCR experiment and should be done carefully. Primer sequences must be chosen to target the unique DNA of interest, avoiding the possibility of binding to a similar sequence. They should have similar melting temperatures because the annealing step occurs simultaneously for both strands. The melting temperature of a primer can be impacted by the percentage of bases that are guanine (G) or cytosine (C) compared to adenine (A) or thymine (T), with higher GC contents increasing melting temperatures. Adjusting primer lengths can help to compensate for this in matching a primer pair. It is also important to avoid sequences that will tend to form secondary structures or primer dimers, as this will reduce PCR efficiency. Many free online tools are available to aid in primer design.Deoxynucleotide triphosphates (dNTPs): these serve as the building blocks to synthesize the new strands of DNA and include the four basic DNA nucleotides (dATP, dCTP, dGTP, and dTTP). dNTPs are usually added to the PCR reaction in equimolar amounts for optimal base incorporation.PCR buffer: the PCR buffer ensures that optimal conditions are maintained throughout the PCR reaction. The major components of PCR buffers include magnesium chloride (MgCl2), tris-HCl and potassium chloride (KCl). MgCl2 serves as a cofactor for the DNA polymerase, while tris-HCl and KCl maintain a stable pH during the reaction.The PCR reaction is carried out in a single tube by mixing the reagents mentioned above and placing the tube in a thermal cycler.The PCR amplification consists of three defined sets of times and temperatures termed steps: denaturation, annealing, and extension (Figure 1).

Figure 1: Steps of a single PCR cycle.

Each of these steps, termed cycles, is repeated 30-40 times, doubling the amount of DNA at each cycle and obtaining amplification (Figure 2).

Figure 2: The different stages and cycles of DNA molecule amplification by PCR.

Let's take a closer look at each step.

The first step of PCR, called denaturation, heats the template DNA up to 95 C for a few seconds, separating the two DNA strands as the hydrogen bonds between them are rapidly broken.

The reaction mixture is then cooled for 30 seconds to 1 minute. Annealing temperatures are usually 50 - 65 C however, the exact optimal temperature depends on the primers' length and sequence. It must be carefully optimized with every new set of primers.

The two DNA strands could rejoin at this temperature, but most do not because the mixture contains a large excess of primers that bind, or anneal, to the template DNA at specific, complementary positions. Once the annealing step is completed, hydrogen bonds will form between the template DNA and the primers. At this point, the polymerase is ready to extend the DNA sequence.

The temperature is then raised to the ideal working temperature for the DNA polymerase present in the mixture, typically around 72 C, 74 C in the case of Taq.

The DNA polymerase attaches to one end of each primer and synthesizes new strands of DNA, complementary to the template DNA. Now we have four strands of DNA instead of the two that were present to start with.

The temperature is raised back to 94 C and the double-stranded DNA molecules both the "original" molecules and the newly synthesized ones denature again into single strands. This begins the second cycle of denaturation-annealing-extension. At the end of this second cycle, there are eight molecules of single-stranded DNA. By repeating the cycle 30 times, the double-stranded DNA molecules present at the beginning are converted into over 130 million new double-stranded molecules, each one a copy of the region of the starting molecule delineated by the annealing sites of the two primers.

To determin
e if amplification has been successful, PCR products may be visualized using gel electrophoresis, indicating amplicon presence/absence, size and approximate abundance. Depending on the application and the research question, this may be the endpoint of an experiment, for example, if determining whether a gene is present or not. Otherwise, the PCR product may just be the starting point for more complex downstream investigations such as sequencing and cloning.

Thanks to their versatility, PCR techniques have evolved over recent years leading to the development or several different types of PCR technology.

Some of the most widely used ones are:

One of the most useful developments has been quantitative real-time PCR or qPCR. As the name suggests, qPCR is a quantitative technique that allows real-time monitoring of the amplification process and detection of PCR products as they are made.2 It can be used to determine the starting concentration of the target DNA, negating the need for gel electrophoresis in many cases. This is achieved thanks to the inclusion of non-specific fluorescent intercalating dyes, such as SYBR Green, that fluoresce when bound to double-stranded DNA, or DNA oligonucleotide sequence-specific fluorescent probes, such as hydrolysis (TaqMan) probes and molecular beacons. Probes bind specifically to DNA target sequences within the amplicon and use the principle of Frster Resonance Energy Transfer (FRET) to generate fluorescence via the coupling of a fluorescent molecule on one end and a quencher at the other end. For both fluorescent dyes and probes, as the number of copies of the target DNA increases, the fluorescence level increases proportionally, allowing real-time quantification of the amplification with reference to standards containing known copy numbers (Figure 3).

qPCR uses specialized thermal cyclers equipped with fluorescent detection systems that monitor the fluorescent signal as the amplification occurs.

Figure 3: Example qPCR amplification plot and standard curve used to enable quantification of copy number in unknown samples.

Reverse transcription (RT) -PCR and RT-qPCR are two commonly used PCR variants enabling gene transcription analysis and quantification of viral RNA, both in clinical and research settings.

RT is the process of making cDNA from single-stranded template RNA3 and is consequently also called first-strand cDNA synthesis. The first step of RT-PCR is to synthesize a DNA/RNA hybrid between the RNA template and a DNA oligonucleotide primer. The reverse transcriptase enzyme that catalyzes this reaction has RNase activity that then degrades the RNA portion of the hybrid. Subsequently, a single-stranded DNA molecule is synthesized by the DNA polymerase activity of the reverse transcriptase. High purity and quality starting RNA are essential for a successful RT-PCR.

RT-PCR can be performed following two approaches: one-step RT-PCR and two-step RT-PCR. In the first case, the RT reaction and the PCR reaction occur in the same tube, while in the two-step RT-PCR, the two reactions are separate and performed sequentially.

The reverse transcription described above often serves as the first step in qPCR too, quantifying RNA in biological samples (either RNA transcripts or derived from viral RNA genomes).

As with RT-PCR, there are two approaches for quantifying RNA by RT-qPCR: one-step RT-qPCR and two-step RT-qPCR. In both cases, RNA is first reverse-transcribed into cDNA, which is used as the template for qPCR amplification. In the two-step method, the reverse transcription and the qPCR amplification occur sequentially as two separate experiments. In the one-step method, RT and qPCR are performed in the same tube.

Digital PCR (dPCR) is another adaptation of the original PCR protocol.4 Like qPCR, dPCR technology uses DNA polymerase to amplify target DNA from a complex sample using a primer set and probes. The main difference, though, lies in the partitioning of the PCR reactions and data acquisition at the end.

dPCR and ddPCR are based on the concept of limiting dilutions. The PCR reaction is split into large numbers of nanoliter-sized sub-reactions (partitions). The PCR amplification is carried out within each droplet. Following PCR, each droplet is analyzed with Poisson statistics to determine the percentage of PCR-positive droplets in the original sample. Some partitions may contain one or more copies of the target, while others may contain no target sequences. Therefore, partitions classify either as positive (target detected) or negative (target not detected), providing the basis for a digital output format.

ddPCR is a recent technology that became available in 2011.5 ddPCR utilizes a water-oil emulsion to form the partitions that separate the template DNA molecules. The droplets essentially serve as individual test tubes in which the PCR reaction takes place.

The recent development of microfluidic handling systems with microchannels and microchambers has paved the way for a range of practical applications, including the amplification of DNA via PCR on microfluidic chips.

PCR performed on a chip benefits from microfluidics advantages in speed, sensitivity and low consumption of reagents. These features make microfluidic PCR particularly appealing for point-of-care testing, for example, for diagnostics applications. From a practical point of view, the sample flows through a microfluidic channel, repeatedly passing the three temperature zones reflecting the different steps of PCR. It takes just 90 seconds for a 10 L sample to perform 20 PCR cycles.6 The subsequent analysis can then be easily carried out off-chip.

The different PCR approaches all have advantages and disadvantages that impact the applications to which they are suited 7. These are summarized in Table 1.

Approach

Advantages

Limitations

PCR

Easiest PCR to perform

Low cost of equipment and reagents

Several downstream applications (e.g., cloning)

Results are only qualitative

Requires post-amplification analyses that increase time and risk of error

Products may need to be confirmed by sequencing

qPCR

Produces quantitative results

Probe use can ensure high specificity

High analytical sensitivity

Low turnaround time

Eliminates requirements for post-amplification analysis

Requires more expensive reagents and equipment

Less flexibility in primer and probe selection

Less amenable to other downstream product confirmation analyses (such as sequencing) due to the small length of the amplicon

Not suitable for some downstream applications such as cloning

RT-PCR and RT-qPCR

Can be used with all RNA types

RNA is prone to degradation

The RT step may increase the time and potential for contamination

dPCR and ddPCR

Fast

No DNA purification step

Provides absolute quantification

Increased sensitivity for detecting the target in limited clinical samples

Highly scalable

Costly

Based on several statistical assumptions

Microfluidic PCR

Accelerated PCR process

Reduced reagent consumption

Can be adapted for high throughput

Portable device for point-of-care applications

Allows single-cell analysis

Still very new technology

Requires extensive sample preparation to remove debris and unwanted compounds

Restricted choice of materials for the microfluidic device due to high temperatures

Table 1: Key advantages and disadvantages of different PCR approaches.

PCR has become an indispensable tool in modern molecular biology and has completely transformed scientific research. The technique has also opened up the investigation of cellular and molecular processes to those outside the field of molecular biology and consequently also finds utility by scientists in many disciplines.

Whilst PCR is itself a powerful standalone technique, it has also been incorporated into wider techniques, suc
h as cloning and sequencing, as one small but important part of these workflows.

Research applications of PCR include:

Gene transcription -PCR can examine variations in gene transcription among cell types, tissues and organisms at a specific time point. In this process, RNA is isolated from samples of interest, and reverse-transcribed into cDNA. The original levels of RNA for a specific gene can then be quantified from the amount of cDNA amplified in PCR.Genotyping -PCR can detect sequence variations in alleles of specific cells or organisms. A common example is the genotyping of transgenic organisms, such as knock-out and knock-in mice. In this application, primers are designed to amplify either a transgene portion (in a transgenic animal) or the mutation (in a mutant animal).Cloning and mutagenesis- PCR cloning is a widely used technique where double-stranded DNA fragments amplified by PCR are inserted into vectors (e.g., gDNA, cDNA, plasmid DNA). This for example, enables the creation of bacterial strains from which genetic material has been deleted or inserted. Site-directed mutagenesis can also be used to introduce point mutations via cloning. This often employs a technique known as recombinant PCR, in which overlapping primers are specifically designed to incorporate base substitutions (Figure 4). This technique can also be used to create novel gene fusions.

Figure 4: Diagram depicting an example of recombinant PCR.Sequencing- PCR can be used to enrich template DNA for sequencing. The type of PCR recommended for the preparation of sequencing templates is called high-fidelity PCR and is able to maintain DNA sequence accuracy. In Sanger sequencing, PCR-amplified fragments are then purified and run in a sequencing reaction. In next-generation sequencing (NGS), PCR is used at the library preparation stage, where DNA samples are enriched by PCR to increase the starting quantity and tagged with sequencing adaptors to allow multiplexing. Bridge PCR is also an important part of the second-generation NGS sequencing process.Both as an independent technique and as a workhorse within other methods, PCR has transformed a range of disciplines. These include:

Genetic research- PCR is used in most laboratories worldwide. One of the most common applications is gene transcription analysis9, aimed at evaluating the presence or abundance of particular gene transcripts. It is a powerful technique in manipulating the genetic sequence of organisms animal, plant and microbe - through cloning. This enables genes or sections of genes to be inserted, deleted or mutated to engineer in genetic markers alter phenotypes, elucidate gene functions and develop vaccines to name but a few. In genotyping, PCR can be used to detect sequence variations in alleles in specific cells or organisms. Its use isnt restricted to humans either. Genotyping plants in agriculture assists plant breeders in selecting, refining, and improving their breeding stock. PCR is also the first step to enrich sequencing samples, as discussed above. For example, most mapping techniques in the Human Genome Project (HGP) relied on PCR.Medicine and biomedical research- PCR is used in a host of medical applications, from diagnostic testing for disease-associated genetic mutations, to the identification of infectious agents. Another great example of PCR use in the medical realm is prenatal genetic testing. Prenatal genetic testing through PCR can identify chromosome abnormalities and genetic mutations in the fetus, giving parents-to-be important information about whether their baby has certain genetic disorders. PCR can also be used as a preimplantation genetic diagnosis tool to screen embryos for in vitro fertilization (IVF) procedures.Forensic science- Our unique genetic fingerprints mean that PCR can be instrumental in both paternity testing and forensic investigations to pinpoint samples' sources. Small DNA samples isolated from a crime scene can be compared with a DNA database or with suspects' DNA, for example. These procedures have really changed the way police investigations are carried out. Authenticity testing also makes use of PCR genetic markers, for example, to determine the species from which meat is derived. Molecular archaeology too utilizes PCR to amplify DNA from archaeological remains.Environmental microbiology and food safety- Detection of pathogens by PCR, not only in patients' samples but also in matrices like food or water, can be vital in diagnosing and preventing infectious disease.PCR is the benchmark technology for detecting nucleic acids in every area, from biomedical research to forensic applications. Kary Mullis's idea, written on the back of a receipt on the side of the road, turned out to be a revolutionary one.

References1. Chien A, Edgar DB, Trela JM. Deoxyribonucleic acid polymerase from the extreme thermophile Thermus aquaticus. J Bacteriol 1976;127(3):1550-57 doi: 10.1128/JB.127.3.1550-1557.1976

2. Saiki RK, Scharf S, Faloona F, et al. Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 1985;230(4732):1350 doi: 10.1126/science.2999980

3. Arya M, Shergill IS, Williamson M, Gommersall L, Arya N, Patel HRH. Basic principles of real-time quantitative PCR. Expert Review of Molecular Diagnostics 2005;5(2):209-19 doi: 10.1586/14737159.5.2.209

4. Bachman J. Chapter Two - Reverse-Transcription PCR (RT-PCR). In: Lorsch J, ed. Methods in Enzymology: Academic Press, 2013:67-74. doi : 10.1016/B978-0-12-420037-1.00002-6

5. Morley AA. Digital PCR: A brief history. Biomol Detect Quantif 2014;1(1):1-2 doi: 10.1016/j.bdq.2014.06.001

6. Taylor SC, Laperriere G, Germain H. Droplet Digital PCR versus qPCR for gene expression analysis with low abundant targets: from variable nonsense to publication quality data. Scientific Reports 2017;7(1):2409 doi: 10.1038/s41598-017-02217-x

7. Ahrberg CD, Manz A, Chung BG. Polymerase chain reaction in microfluidic devices. Lab on a Chip 2016;16(20):3866-84 doi: 10.1039/C6LC00984K

8. Garibyan L, Avashia N. Polymerase chain reaction. J Invest Dermatol 2013;133(3):1-4 doi: 10.1038/jid.2013.1

9. VanGuilder HD, Vrana KE, Freeman WM. Twenty-five years of quantitative PCR for gene expression analysis. BioTechniques 2008;44(5):619-26 doi: 10.2144/000112776

Read the original post:
An Introduction to PCR - Technology Networks

Once bitten, twice shy: the neurology of why one bad curry could put us off for life – Newswise

Newswise A negative experience with food usually leaves us unable to stomach the thought of eating that particular dish again. Using sugar-loving snails as models, researchers at the University of Sussex believe these bad experiences could be causing a switch in our brains, which impacts our future eating habits.

Like many other animals, snails like sugar and usually start feeding on it as soon as it is presented to them. But through aversive training which involved tapping the snails gently on the head when sugar appeared, the snails' behaviour was altered and they refused to feed on the sugar, even when hungry.

When the team of Sussex Neuroscience researchers led by Dr Ildiko Kemenes looked a little closer, they discovered a neuronal mechanism that effectively reversed the snails' usual response to sugar after the conditioning training had taken place.

Dr Ildiko Kemenes, Reader in Neuroscience in the University of Sussex's School of Life Sciences, explained: "There's a neuron in the snail's brain which normally suppresses the feeding circuit. This is important, as the network is prone to becoming spontaneously activated, even in the absence of any food. By suppressing the feeding circuit, it ensures that the snail doesn't just eat everything and anything. But when sugar or other food stimulus is present, this neuron becomes inhibited so that feeding can commence.

"After the aversive training, we found that this neuron reverses its electrical response to sugar and becomes excited instead of inhibited by it. Effectively, a switch has been flipped in the brain which means the snail no longer eats the sugar when presented with it, because sugar now suppresses rather than activates feeding."

When researchers presented the trained snails with a piece of cucumber instead, they found that the animal was still happy to eat the healthy option - showing that the taps were associated with only the particular type of food they were trained to reject.

George Kemenes, Professor of Neuroscience at the University of Sussex and a senior member of the investigator team, added: "Snails provide us with a similar yet exceptionally basic model of how human brains work.

"The effect of the inhibitory neuron which suppresses the feeding circuit in the snail is quite similar to how, in the human brain, cortical networks are under inhibitory control to avoid 'runaway' activation which may lead to overeating resulting in obesity.

"In our research, the negative experience the snail had with the sugar could be likened to eating a bad takeaway curry which then puts us off that particular dish in future.

"We believe that in a human brain, a similar switch could be happening where particular groups of neurons reverse their activity in line with the negative association of a particular food. "

The research, funded by the Biotechnology and Biological Sciences Research Council (BBSRC) and published inCurrent Biology, also revealed that when the neuron was removed entirely from trained snails, they returned to eating sugar again.

Dr Ildiko Kemenes said: "This suggests that the neuron is necessary for the expression of the learned behaviour and for altering the response to sugar.

"However, we cannot rule out that the sugar-activated sensory pathway also undergoes some changes, so we don't make the assumption that this is all that's happening in the brain."

###

Visit link:
Once bitten, twice shy: the neurology of why one bad curry could put us off for life - Newswise

Overweight/Obesity in Young Adulthood Linked to Increased Risk of MS – Neurology Advisor

Overweight/obese levels of BMI at age 20, paired with history of infectious mononucleosis (IM) or high Epstein-Barr nuclear antigen 1 (EBNA-1) antibody levels, synergize in elevating the risk of multiple sclerosis (MS), and the effect strengthens with increasing antibody levels, according to study results published in Neurology: Neuroimmunology & Neuroinflammation. Results also indicated significant 3-way additive interactions between DRB1*15:01 allele, BMI at age 20 years, and each aspect of Epstein Barr virus (EBV) infection.

The study researchers sought to find out whether these MS risk factors had an additive interaction for the inflammatory disease, and to analyze 3-way interactions between BMI at age 20, EBV infection, and the human leukocyte antigen (HLA)-DRB1* 15:01 allele.

They used data from the Epidemiological Investigation of Multiple Sclerosis (EIMS) and Genes and Environment in Multiple Sclerosis (GEMS) studies, 2 Swedish population-based case-control studies on environmental and genetic risk factors for MS. In the former, newly diagnosed cases of MS were recruited from neurology clinics and matched with 2 randomly selected controls from the countrys national population register, frequency matched in 5-year age strata, sex, and residential area. GEMS presented prevalent cases of MS from the Swedish National MS Registry, each of whom was matched with 1 control in the same way as in EIMS.

The study researchers also included controls from the Epidemiological Investigation of Rheumatoid Arthritis, which was designed in the same manner and with a similar study population as EIMS. Participants provided blood samples for the genotyping and self-reported contraction of IM, body height, and weight.

The combination of two risk factors, overweight/obesity at age 20 years and a history of IM, synergistically increased the risk of MS 5-fold. In contrast, nonoverweight subjects with IM history had a 90% increased risk of MS and those with overweight/obesity at age 20 years (BMI I 25 kg/m2) without IM history had a 40% increased MS risk.

BMI at age 20 years and high EBNA-1 antibody levels, even without history of IM, had a similar interaction that increased with elevated EBNA-1 antibody levels.

2-way interactions were present between DRB1*15:01 and overweight/obesity at age 20 years, between DRB1*15:01 and each aspect of EBV infection, and between overweight/obesity at age 20 years and each aspect of EBV infection. DRB1*15:01, BMI at age 20 years, and each aspect of EBV infection (IM history and high EBNA-1 antibody levels, respectively) had significant 3-way interactions.

These findings held significant for both EIMS and GEMS when investigators restricted the analysis to subjects with complete data on HLA alleles and EBNA-1 antibody levels.

Limitations of the study included selection bias and recall bias in the studies and risk of misclassification when dichotomizing subjects into those with and without self-reported IM history.

The study researchers concluded, The obese state both induces a chronic immune-mediated inflammation and affects the cellular immune response to infections, which may contribute to explain our findings. They added that their data reinforce the importance of intervention efforts against childhood and adolescent obesity to reduce MS incidence.

Disclosure: Several authors declared affiliations with the pharmaceutical industry. Please see the original reference for a full list of authors disclosures.

Reference

Hedstrm AK, Brenner N, Butt J, et al. Overweight/obesity in young adulthood interacts with aspects of EBV infection in MS etiology. Neurol Neuroimmunol Neuroinflamm. Published online December 15, 2020. doi:10.1212/NXI.0000000000000912

Read the rest here:
Overweight/Obesity in Young Adulthood Linked to Increased Risk of MS - Neurology Advisor

Acute neurologic manifestations in children with hemolytic uremic syndrome linked to increased mortality – 2 Minute Medicine

1. In a largemulti-centerstudy of children with hemolytic uremic syndrome, those with any acute neurologic manifestation (ANM) had increased risk of mortality.

2. Brain infarction, brain hemorrhage, anoxic brain injury, and brain edema were independently associated with mortality.

Evidence Rating Level: 2 (Good)

Study Rundown:Hemolytic uremic syndrome (HUS) is a microangiopathic hemolytic anemia characterized by anemia, thrombocytopenia, and renal dysfunction. One of the most serious complications of HUS is neurologic injury, which can lead to devastating sequelae including death. Previously, only small studies examined acute neurologic manifestations (ANMs) of HUS, with widely varying conclusions. This study characterized ANMs and their association with in-hospital mortality in nearly 4,000 children with HUS using a database containing information from over 40 childrens hospitals in North America. Overall, ANMs occurred in 10.4% of patients. Mortality was significantly higher in patients with any ANM (13.9%) compared to those without an ANM (1.8%). Furthermore, mortality was higher in patients with 2 ANMs (17.6%) than in those with 1 ANM (11.9%). Researchers also examined risk of mortality with specific ANMs and specific combinations of ANMs. One important limitation of this study was the lack of differentiation between typical and atypical HUS, which are considered to be different disease processes. Overall, this robust analysis of data obtained from a large database provides valuable information in identifying which children with HUS are at risk for worse outcomes.

Click to read the study in Pediatrics

Relevant Reading: Neurological involvement in children with E. coli 0104:H4-induced hemolytic uremic syndrome

In-Depth [retrospective cohort]: Data was obtained from the Pediatric Health Information System database, which contains information from over 40 tertiary childrens hospitals in North America. Overall, 3915 children (52.5% female, 75.5% white, median age 3.8 years) with HUS were included in the study. The median age of patients with ANMs was 3.3 years. In addition to increased mortality in patients with ANMs, average length of stay was also longer in those with ANMs compared to those without (27.8 vs. 13.8 days, p<0.001). The three most common ANMs were encephalopathy (60% of all patients with ANMs), seizures (26.4%), and stroke (22.5%). Mortality varied between specific ANMs encephalopathy (4.3%), seizures (8.9%), meningitis (21.7%), stroke (22.2%), intracranial hemorrhage (40%), cerebral edema (25%), and anoxic brain injury (40%). Patients < 30 days old were at increased risk of mortality, as were those who required mechanical ventilation or ECMO. ANMs independently associated with mortality were brain infarction (OR 2.64, p=0.03), brain hemorrhage (OR 3.09, p=0.005), anoxic brain injury (OR 3.92, p=0.006), and brain edema (OR 4.81, p=0.002).

Image: PD

2020 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Continue reading here:
Acute neurologic manifestations in children with hemolytic uremic syndrome linked to increased mortality - 2 Minute Medicine

Ben-Gurion University Researchers Introduce New Method for Diagnosing Neurological and Psychiatric Conditions – PRNewswire

BEER-SHEVA, Israel, Feb. 9, 2021 /PRNewswire/ -- Researchers at Ben-Gurion Universityof the Negev (BGU) have developed a new method for rapidly diagnosing brain blood vessel pathology that may lead to neurodegenerative diseases, such as Alzheimer's disease, as well as other neurological and psychiatric conditions, including epilepsy, traumatic brain injury and stroke. The novel method is based on analysis of EEG patterns using proprietary algorithms and was invented by Dr. Dan Milikovsky and Prof. Alon Friedman, MD-PhD, Departments of Physiology and Cell Biology, Cognitive and Brain Sciences, Zlotowski Center for Neuroscience, Ben-Gurion University of the Negev.

The novel diagnostic method is based on findings from the lab of Prof. Friedman that patients with Alzheimer's disease and other brain conditions display nonconvulsive epileptic seizure-like activity that can be detected by EEG recordings. The study was published in the highly ranked Science Translational Medicine Journal [i]. This abnormal activity reflects pathological changes in dysfunction of the brain blood vessels, which contribute, according to recent studies, to the pathogenesis of various neurodegenerative and other neuro-psychiatric disorders.

"Research from our lab and others, shows that the pathological changes in the brain blood vessels, which are usually referred to as the blood-brain barrier (BBB), contribute to the formation of Alzheimer's disease and other brain disorders. Since dysfunction of the BBB is also a key component in the pathogenesis of epilepsy, we hypothesized that BBB dysfunction in Alzheimer's patients would also trigger abnormal brain activity that could be detected by EEG, an accessible and affordable tool used in the clinic, and serve as a diagnostic method for these conditions," explained Prof. Friedman. "Indeed, we find abnormal, epileptic-like EEG recordings in many patients with Alzheimer's disease as well as epilepsy, which reflect brain blood vessel pathology and can serve both for diagnosis as well as a therapeutic target."

The technology was successfully tested on animal models and dozens of patients and is now been validated on large databases of EEG records of thousands of patients.

"This new approach for diagnosing neurological conditions based on analysis of changes of blood vessels in the brain can be valuable for the early detection of Alzheimer's disease and other neurological conditions, at the stage when treatment can still slow down disease progression. The technology offers a biomarker for immediate results and allows for the continuous monitoring of the progression of the neurological condition and response to treatment," said Josh Peleg, CEO of BGN Technologies. "We are now seeking a potential industry partner for the further development of this promising method for a variety of applications, from monitoring of ICU patients, to patients after stroke and head injuries and for the diagnosis of vascular pathology in early Alzheimer's disease."

About BGN Technologies

BGN Technologiesis the technology transfer companyof Ben-Gurion University, the third largest university in Israel. BGN Technologies brings technological innovations from the lab to the market and fosters research collaborations and entrepreneurship among researchersand students. To date, BGNTechnologieshas established over 100 startup companiesin the fields of biotech, hi-tech, and cleantech, and has initiated leading technology hubs,incubators, and accelerators.Over the past decade, BGN Technologies has focused on creating long-term partnerships with multinational corporations such as Deutsche Telekom, Dell-EMC, PayPal, and Lockheed Martin, securing value and growth for Ben-Gurion University as well as the Negev region.For more information, visit the BGN Technologies website.

[i] Milikovsky1 et al. (Dec. 2019), Paroxysmal slow cortical activity in Alzheimer's disease and epilepsy is associated with blood-brain barrier dysfunction. Science Translational Medicine: Vol. 11, Issue 521, eaaw8954.

Media Contact:Tsipi HaitovskyGlobal Media LiaisonBGN TechnologiesTel: +972-52-598-9892E-mail: [emailprotected]

SOURCE BGN Technologies

See more here:
Ben-Gurion University Researchers Introduce New Method for Diagnosing Neurological and Psychiatric Conditions - PRNewswire

Anesthesia Masks Market: Rising Prevalence of Chronic Diseases and Neurological Disorders to Drive the Market – BioSpace

Anesthesia Masks Market: Overview

Read Report Overview - https://www.transparencymarketresearch.com/anesthesia-masks-market.html

Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=74771

Key Drivers of Global Anesthesia Masks Market

Request for Analysis of COVID-19 Impact on Anesthesia Masks Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=74771

North America to Hold Major Share of Global Anesthesia Masks Market

Request for Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=74771

Pre Book Anesthesia Masks Market Report at https://www.transparencymarketresearch.com/checkout.php?rep_id=74771&ltype=S

Key Players Operating in Global Market

Major players operating in the global anesthesia masks market are:

Browse More Trending Reports by Transparency Market Research:

Flow Diversion Aneurysm Market: https://www.transparencymarketresearch.com/flow-diversion-aneurysm-market.html

Bacteremia Treatment Market: https://www.transparencymarketresearch.com/bacteremia-treatment-market.html

Whipples Disease Market: https://www.transparencymarketresearch.com/whipples-disease-market.html

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

ContactMr. Rohit BhiseyTransparency Market ResearchState Tower,90 State Street,Suite 700,Albany NY - 12207United StatesUSA - Canada Toll Free: 866-552-3453Email: sales@transparencymarketresearch.comWebsite: https://www.transparencymarketresearch.com/

Follow this link:
Anesthesia Masks Market: Rising Prevalence of Chronic Diseases and Neurological Disorders to Drive the Market - BioSpace

Anatomy of an Impeachment Trial – The Dispatch – The Dispatch

Were on day two of the Senates second impeachment trial of Donald Trump and our hosts are here for the breakdown. On Tuesday, the House impeachment managers released a video montage of January 6 in an effort to tie former President Trumps rhetoric and words to the storming of the Capitol. [The video] had in many ways the effect that displaying a crime scene photograph has on a criminal trial, David explains. It tried to make it real again. Tune in to hear Sarah and the guys chat about the constitutionality of impeachment, the mechanics of the trial, and the persuasiveness of Trumps defense team. Stick around to hear our hosts chat about what National Pizza Day means to them.

Show Notes:

-Senate Impeachment Trial: House Managers January 6 Video Montage.

-French Press:The Impeachment Trial Vote Will Set a Precedent. Make It the Right One. by David French inThe Dispatch.

-Brandenburg v. Ohio

-McConnell Signals Trump Conviction Is a GOP Conscience Vote by Jennifer Jacobs inBloomberg.

-The Constitution Doesnt Bar Trumps Impeachment Trial by Chuck Cooper in theWall Street Journal.

See original here:
Anatomy of an Impeachment Trial - The Dispatch - The Dispatch

Video: ‘Judas and the Black Messiah’ | Anatomy of a Scene – The New York Times

My name is Shaka King. Im the co-writer, director, and one of the producers on Judas and the Black Messiah. This scene happens pretty early in the movie. William ONeal, played by Lakeith Stanfield, has just used a fake FBI badge to steal a car and get arrested for that. And here, he meets FBI agent Roy Mitchell, played by Jesse Plemons. So the first shot that we saw earlier was of ONeals feet and blood seemingly falling from where you dont know. It could be from his face. It could be from his hands. And its a time jump. You havent seen the assault that occurred on ONeal. And with us, we were trying to, as early as possible, just establish that this is a film that is not going to give you a lot of exposition. its not going to kind of hold your hand through this experience. We want you as a viewer to fill in the blanks with your imagination as much as possible. Because ideally, we believe that it puts you in the perspective of the person in the movie. This scene is one of the most important scenes in the movie, because it highlights a key factor that were trying to get across to audiences, which is, in a lot of ways, this scene is about the danger of being apolitical. We really wanted to hit home the old phrase, if you stand for nothing, youll fall for anything. Were you upset when Dr. King was murdered? What? Were you upset when Dr. King was murdered? I dont know. We see William ONeal questioned by Roy Mitchell about how he felt after Martin Luther Kings assassination. ONeal admits that it bothered him somewhat. And then, when Mitchell asked him how he felt about Malcolm Xs assassination, and ONeal says, I never really thought about it. And you see Roy Mitchell, in response to that question, smile a little bit, because hes found the person that he thinks is a perfect informant. In terms of how we employed the close-ups, I knew we wanted to save our most extreme close-ups for ONeals look up at the end. That is a pleading look of, like, get me out of here. Ill do anything to get out of here.

See more here:
Video: 'Judas and the Black Messiah' | Anatomy of a Scene - The New York Times

Dissecting Anatomy Lab: The Lifecycle of Anatomy Instruction – Pager Publications, Inc.

Editors Note: We are featuring a series of essays by Kate Crofton on anatomy lab. Her essays are based on 27 interviews with medical students, faculty, clinicians and donors. This is the third installment in the series. Read the second installment here.

It is the day before the first anatomy lab for the first-year medical students, and a single professor walks alone, up and down rows of tables laden with twenty-six naked, embalmed bodies. He silently shares a few minutes with the donors, a private thank-you. Soon the donors will be covered in white sheets, and the students will tentatively spill through the locked wooden doors of the labs, a rush of anticipation, teamwork, questions and learning. But right now, no one makes a sound. There is no buzzing of saws, whirring of the suction machine, or gentle clinking of hemostats and Metzenbaum scissors against the metal tables, no nervous laughter, exclamations of discovery or confused mumblings.

The professor will be joined by an eclectic team of his colleagues. They are educators who use dead people as their teaching medium. They spend hours on end in rooms reeking of formaldehyde. Above all, they care deeply about doing their work with respect. With their turquoise gloves, blue paper surgical shoe covers, rainbow of expo markers, memorized atlas page numbers, thoracic spine necklaces, golden dissecting scissors and pockets full of little colored wires, they will help each student learn to find their way.

These professors find beauty in anatomy: the relationships of the structures to each other, the functionality of the human body, unique variations and even pathology. The brachial plexus dissection is a favorite of one professor, a lab which reveals a complicated bundle of nerves branching and recombining to serve the arm. For another, the most beautiful structures are the hands and the head, the parts worn outside of clothing that express personality and individuality. They love the search for structures: When you first look at the tissue, it looks like a messnon-descript gauze. There is no real reason to think there are nerves or vessels running through that. But then once you find them and then you see how tightly packed things are, you realize just how incredible it is.

Another instructor asserts that her upbringing in a family of hunters contributed to her early interest in anatomy and her understanding of the place of death in the lifecycle. My brothers and my dad hunted, and so from the time that I was really little, I was used to seeing deer butchered in our garage. I was struck by the intricacy and the beauty of how a body could be put together and function properly I can remember my mom buying one pound of ground beef, and she would make our meals for the week goulash, Spanish rice, things that would spread it out. I realized that deer put meat on our table and kept deer from starving; it managed the population. Death is a natural part of life.

My dad and brother are also deer hunters, and I remember deer carcasses hanging in my dads shop during my childhood. I perched on overturned five-gallon buckets amidst sawdust and pine two-by-fours and watched as my dad sliced away the hide and wrapped chunks of bloody meat in crisp white freezer paper. I loved the warm, buttery taste of venison and intuited more easily then the cycling of life into death into life again. The deer were beautiful, running through our hay fields, and they were beautiful still as carved up slabs of meat in the deep freezer.

To find beauty in the anatomy lab might seem crass; after all the mechanical process of disassembling the donor is brutal, and at the end the body is a carcass, a dried-out pile of flayed skin and bones. Professors acknowledge this difficulty, I am always intrigued by different things that I see in the lab beautiful dissections and I know the word beautiful is sometimes a complicated word in that space Youre right, its by seeing many donors over time that you come to appreciate that were all the same, theres a pattern, but were also all unique. Everybody has an interesting story, and their body often tells that.

I interrogate the professors for a list of the most fascinating anatomy theyve seen. They oblige with developmental abnormalities: situs inversus, horse-shoe kidneys, bifid muscles, extra blood vessels and abnormal arrangements of nerves. They also mention impressive pathology: swollen cirrhotic livers, big black lymphatic balls of cancer, white hardened atherosclerotic plaque, occluded coronary vessels and cerebral hemorrhages. They recount biomedical devices and remnants of medical procedures, too, a demonstration of medicines advances to thwart pathology: coronary bypasses and stents, pacemakers, orthopedic prosthetics and deep-brain-stimulating electrodes.

I ask one professor if theres any anatomical anomaly that hes still hoping to see in his career. He gently chides, No, its not like Im going to go out looking for donors to have things that Im interested in; thats not the point. And I realize that I have indeed missed the point. The anatomists dont see donors as collections of interesting or rare anatomy but instead see them as their partners in teaching us.

The anatomy instructors are guardians. One professor explains that she feels a deep sense of responsibility to take care of the donors so that they may teach her students, Its funny, Ive described myself as the curator of those donors. I feel like Im a caretaker of sorts. When I walk into that anatomy lab, I find it to be a very comforting space. When I go in there its quiet and I think about the various lives that are represented by the donors in there, and I think about that gift that they were willing to share to let all of you learn.

I picture an art gallery, with paintings carefully framed on the walls. The anatomy instructor appears, robed in a long white coat and blue scrubs, hair held in place precisely with a barrette. She softly dusts each painting, adjusts the lighting, and adds a placard underneath each one so that it may be better understood. My job is to make sure that all of them are cared for well and that they are the best learning tool for all of you to learn that anatomy and have it be memorable.

The relationship between professor and donor can prompt reflection and even conflict, in the professor. When a young medical professional died of a drug overdose and donated his body to medical education, it provoked one lab instructor to be more reflective than usual. An eighty-seven-year-old died of a heart attack Ive heard that one before, but a twenty-seven-year-old is there something thats fundamentally been lost even more in the twenty-seven-year-old? For whatever reason I did stop and think more and feel a little bit sad, not to the point of tears, but sad and reflective.

She pauses, and then continues, I also felt grateful and then felt a little sick about feeling grateful because that dissection was really beautiful. It looked so much like [the anatomy textbook] a lot of the time the muscle integrity, color, shading, shape and distinction. Things werent blending together, there was no marbling of fat infiltrating the muscles. It was such a beautiful, easy dissection and the students learned so much.

These professors didnt always have such mature relationships with the donors. One faculty member recalls her first experience in an anatomy lab as a student, looking at the donor and thinking, I dont know if I recognize you as a personor a dissection tool. I relate deeply to her memory, and it resonates also with many of my interviews with students. As novices in anatomy, its much more difficult and requires a more deliberate effort to switch between viewing the cadaver as a body and as a person. I am cutting the body, and the person is gone, but the person chose for the body to be here. Its clunky. The professors are more fluid with this duality and coexist with it in a more peaceful way.

When I ask the same professor whether she now views the donor as a person or a body she
responds with an analogy: Its like electrons in orbitals. They can be in one place but never in-between. I try to maintain respect for what I imagine as the person that they were in the decision that they made to be here, the life that they had. But at the same time, I dont believe theyre alive anymore or have any sort of soul inhabiting whats left. Theres all this meat and bones left behind, but theres nothing that can be hurt or embarrassed. The donors are gifts, teaching tools, partners and even friends, extending an invitation to come learn.

The anatomy lab is not an immediately comfortable place for everyone, and even the professors, whom we view as our seasoned guides, once needed to habituate to the space. An instructor recalls her first time leading an anatomy course, I had a really profound visceral response to every dissection. For the first half hour walking in there, I felt nauseated, I felt faint. I always made sure I was bracing myself on a table or against a wall just in case, and I didnt admit it to anyone because I was in charge. I recollect my own experience in lab, repeating a silent mantra mind over matter as the room clouded over and the din grew distant, willing myself to remain vertical. Mind over matter carried me through the course for weeks, and I left the lab each day feeling like a soggy balloon, sapped of all emotional reserves.

The professor continues, Ive been trying to figure out what changed. My first time [as a student] I was fine, and this time Im falling apart and not admitting it to anyone. I think a couple things the crazy amount of stress of trying to learn anatomy, run the course and teach all at the same time. Also, in that instructor role, you cant immerse yourself in dissection. Youre walking from one table to another and watching as people make these incisions and take things apart, and you dont have control over it yourself.

She describes being in lab one day when students were dissecting the lower extremity. At that point, the legs had been severed from the trunk of the body, and they were propped at ninety-degree angles to practice the anterior drawer test. A living person might assume the same position, perhaps strewn out on the sofa reading a book, feet on the cushions and knees bent in the air. It didnt feel right, because it [aligned] too much with what I think an intact human looks like. She adapted and the second year developed strategies to be more comfortable as an instructor in the space. I knew that if I could reduce the smell, that helps. I got Vicks Vapor Rub, and I would wear a mask that year. I realized that getting hands-on as soon as possible helped, so I made sure to get in on someones dissection as soon as I got in the room. Partly just seeing it again and again, I habituated.

To our instructors, the donors are far more than dead bodies; they are teachers. Textbooks and plastic models only represent our notion of typical, but donors show us great variation. In an even voice with steady conviction, an anatomy instructor explains, I see [the donors] silently saying Bring the book over here, and if you dont see it, change the book because this is real. The anatomical donor population provides an immediate education of what we currently understand about how human bodies function and some of the ways they stop functioning. The donors inform our knowledge and make us better scientists and clinicians.

They also move us to be better people. Groups in power have historically used pseudoscientific arguments to justify their social status. For example, in the 1800s Samuel George Morton thought that it was possible to define the intellectual ability of a race by skull size. Rigorous scientific methods and access to good data have refuted his racist claims. If our anatomy is all the same, then how can biology determine the inherent superiority of one class of people? As one professor believes, the donors show us the importance of inclusion and respect for all human beings. There used to be quite a bit of wrong speculation of how bodies were put together and how they functioned. Over the past century, we finally have moved into an understanding of how things really work, and the donor population is a large part of the reason why we now understand.

The donors help us understand anatomy, and they also help us come to terms with our own mortality. I ask one professor if anatomy has changed his view of death. He tells me no, rather its the opposite; because of donors, his personal grief has emerged in the classroom. The year that his father died, the first day of class fell on his fathers birthday and there happened to be a cadaver in lab that resembled the professors father. A first-year student in that class had recently lost his mother to breast cancer. When the student peeled back the white sheets in preparation for anterior dissections, he discovered a breast-less chest bearing the scars of a mastectomy, and so we bothhad these acute reminders of the grief that we were going through. When the same professors wife of thirty-eight years died of colon cancer, he knew that he would need to take extra care in order to be able to teach the gastrointestinal anatomy. Well its not like all twenty-six cadavers died of colon cancer. So it wasnt something every day that I had to deal with. The stress for me is the teaching part; I want to make sure that Im doing a good job You put things aside, and you cant be thinking about grief and the death of someone all the time, you just wouldnt be functional. Its not that I intentionally put it aside, its just other things become more important in the moment and then I go home and think about it.

Anatomy instruction has both accelerated and become more humanistic over the last fifty years. A professor contemplates his first anatomy course as a student in the 1970s, I can remember that there were students who put clothes on their cadavers. Surprisingly there was not a lot of student reaction to that; people just werent as thoughtful or as sensitive about it as they are now. We didnt do it, but someone did it to our cadaver. Thats probably my most vivid memory. Decades later, he shifts uneasily in his chair and his eyes moisten. Some of our professors rules make more sense now. Photography is not allowed in the gross anatomy labs, only medical students may enter the locked space, and we are warned to treat the donors with respect for their personhood.

He continues reminiscing, Although [medical school] had a body donation program, we also had unclaimed bodies. Our cadaver was African-American, and Im going to guess that he was unclaimed just from the wear and tear. So thats changed now too, the anatomical program has changed. Anatomical gift programs really began to get formalized in the mid-20th century and werent really codified well until the 1960s. All the cadavers used at our medical school today are donated. I try to imagine what it would feel like to dissect a body that was discarded at the hospital or county morgue, perhaps because the decedents family couldnt afford to pay a bill. It feels ugly. I am grateful for my donors gift of his body, and also immensely grateful that it was a gift. The professor agrees that he is much more comfortable with our exclusively donor-based anatomy program.

A students time in anatomy lab today is abbreviated compared to our professors educations. [My medical anatomy class] had three hundred hours. When I first came here in 1985 we had a one hundred ninety hour [anatomy] course and one hundred sixty [of those hours] were laboratory. We are down now to less than one hundred hours of lab. Surprisingly the detail [that we teach you] hasnt changed that much. We had to become more efficient. Our education today prioritizes early clinical exposure and multi-disciplinary learning. A consequence though, is that it is more difficult for the anatomy professors to get to know their students, and theres less time for students to process the experience as they rush to learn all the material.

What do our anatomy instructors want us to learn? Hopefully some basic ana
tomy, replies a professor, but I know that unless you are using it, its going to disappear. So, Im sure that if I started asking you questions I laugh nervously, and stammer, please dont desperately trying to remember the branching of the cranial nerves in case he does quiz me. Maybe he has a skeleton in his office that he will pick up, pointing to the pinprick fossa of the skull? But he continues, More importantly is when you get to the clerkships during your third and fourth years and someones going to ask you some anatomy do you know where to go to review that? Have we made you a good learner?

Other professors respond, We need to have excellent physicians,and to bean excellent physician you have to know anatomy. The best way to teach anatomy is through dissection.

Equally important, youve learned about yourselves.

You have to learn teamwork, patience, perseverance, humility and gratitude.

Its these moments: watching lightbulbs go off for students as they make a connection across disciplines or overcome challenges, that come up again and again as our teachers biggest joys. Ive always been motivated to teach, and that stems from when I was a little kid taking swimming lessons. By the time that I graduated from tadpole to polliwog, I would help as a teachers aide for the group behind me. I loved when people were able to gain a skill, and I found being part of that process to be very rewarding. I always felt somehow that teaching needed to be part of what I would do for a living. Teaching forms a key part of their identities.

And so, I am surprised, though maybe I shouldnt be, that when I ask if they want to be anatomical donors when they die, a high proportion of our professors responds with an emphatic YES. (One says that if hes healthy enough, hed prefer to be an organ donor. Others qualify that theyd personally be interested in whole body donation but would need to take their familys needs into account, and some havent yet settled on their end of life wishes.) These are people who know with staggering detail everything that happens in the anatomy lab. They know the entire series of maneuvers of the gloved fingers, scalpels, scissors, chisels, and saws required to deconstruct and study what may someday be their cold, bloodless bodies on the dissecting tables.

Its because I know exactly what happens in that space that its important to me. I realize how thorough the dissections are, I realize how much students can learn, I realize how memorable those experiences are, and I realize that it is a space for learning more than just anatomy. If I can support that for one more year, thats incredibly important to me.

I imagine that I am again a first-year student several weeks into gross anatomy lab, and the funeral director visits my table to tell us about our donor. How startling it would be to learn that the body that we had been dissecting belonged to an anatomy professor. One instructor tells me that she loves the ideal of the reveal, Its meta an anatomy professor teaching anatomy again, thats so cool. I am also hoping that it will give comfort to students who feel uncomfortable knowing that theyre dissecting donors who didnt know all the details. [For example] were going to bisect your pelvis thats the one that gets most people to know that most people in the room didnt know that, but heres someone who knew all the nitty gritty details of what was going to happen, and they chose it anyway. I hope that it would give them comfort. They are teachers in life and teachers in death.

Image Credit: Courtesy of the National Library of Medicine. Image is in the public domain.

Contributing Writer

University of Rochester School of Medicine and Dentistry

Kate Crofton is a fourth year medical student at the University of Rochester School of Medicine and Dentistry in Rochester, New York, class of 2021. In 2016, she graduated from Carleton College with a Bachelor of Arts in biology. In her free time, she enjoys writing poetry, reading narrative nonfiction, and baking sourdough. After graduating medical school, Kate intends to pursue a career in OB/GYN.

More:
Dissecting Anatomy Lab: The Lifecycle of Anatomy Instruction - Pager Publications, Inc.

‘Grey’s Anatomy’ Star Jesse Williams Teases Spring Premiere as ‘Pure Madness’ – PopCulture.com

The second half of Grey's Anatomy Season 17 was delayed by a week, but star Jesse Williams promises an exciting return next month. Grey's Anatomy was originally scheduled to return on March 4 but was pushed back a week to Thursday, March 11 at 8 p.m. ET on ABC. When the show last aired, Meredith Grey (Ellen Pompeo) collapsed after seemingly getting better during her COVID-19 struggle. However, the December episode ended with Meredith's condition looking even worse than before.

"It's pure madness," Williams told Entertainment Tonight about the upcoming mid-season premiere. "I've got to say, we have found a way to have really highly concentrated, dense episodes towards the middle of the season with a lot of this incredible combination of loss and joy and progress in these characters' lives. But when [we] come back, yeah, it's going to be fairly terrifying and exhilarating." Williams stars as Dr. Jackson Avery on the show and has also appeared on Station 19 when the two shows cross over.

Each show has covered the coronavirus pandemic in its own way, with Grey's Anatomy putting it front and center during Meredith's illness. Williams said the show's handling of the pandemic has been "really cathartic" for viewers, as characters go through their own personal journeys this season. "Yes, it has value in imagining elsewhere, but theres also value [in] understanding," Williams explained, before comparing the show to the news. He noted that the series helps give names and faces to the statistics viewers see every day, even though the characters are fictional. "These are actual people that have loved ones that were born that his sister and a mom and a brother and theyre struggling with it theyre not just a stat or a demographic so thats important," Williams said.

Williams is also a "little nervous" for Meredith. During the mid-season finale, it looked like Meredith was recovering, and she even helped a patient. Unfortunately, this turned out to be a "COVID high" and she collapsed in the patient's room. The coronavirus symptoms came back quickly, and Meredith was put on a ventilator. Williams has a glimmer of hope for Meredith though. "In a lot of ways, we've all got a lot invested in this and she kind of represents both the sheer terror and the very real and reasonable feeling we have of what's kind of been washing over this," Williams told ET. "But also our fight, our 'stick to it[-ness],' our preparedness, and it really does put into perspective, live your life now."

There is also some hope that other beloved Grey's stars from the past will make appearances. In the first part of the season, Patrick Dempsey made a surprise appearance as Dr. Derek Shepherd in Meredith's dreams. T.R. Knight's George also made a cameo. Showrunner Krista Vernoff said Dempsey will be back, but refused to spoil potential appearances from Sandra Oh, Katherine Heigl, Jeffrey Dean Morgan and others. The only reason why these actors were credited for Season 17 on IMDb was a glitch, Vernoff explained to Variety.

Read the original post:
'Grey's Anatomy' Star Jesse Williams Teases Spring Premiere as 'Pure Madness' - PopCulture.com

Grey’s Anatomy: All The Relationship Statuses Before Season 17 Returns – CinemaBlend

After Teddy Altman (Kim Raver) slept with Tom Koracick (Greg Germann) on her and Owen Hunts wedding day, which was overheard by a whole surgery team via Owens voicemail, Teddy admitted to Owen that she had been in love with her friend Allison, their daughters namesake. Teddy told Owen she knew that fact is related to what happened with Tom, but she wasnt sure how. Owen laughed cruelly at Teddy and said he never knew her at all. We named our daughter after a lie.

As for Koracick, Teddy didn't sound like she was ready to let him go, as she sat at his bedside after his COVID took a bad turn. At the very least she wanted to salvage their friendship, saying there was a ray of hope for them. He woke up and the two shared a strange, flirty exchange, with Tom suggesting a sponge bath, but, you know, as friends. With Owens firm rejection of Teddy in the winter finale, I'm not shutting the door on Tom and Teddy just yet.

See the original post here:
Grey's Anatomy: All The Relationship Statuses Before Season 17 Returns - CinemaBlend

The anatomy of a perfect honeymoon hotel: what to look for and what to avoid – Telegraph.co.uk

If you have love, you dont need anything else, wrote J M Barrie. An eternal truth; and yet a century on, in a world where so many of us have already been everywhere and done everything, there is huge pressure on the honeymoon to be perfect, a no-expense-spared trip of a lifetime. It doesnt need to be. Cutting loose from the world for a while is enough, either in a place you love or somewhere new to discover together.

Choose a place to suit both your souls, where youll be happy for a week or two, particularly in a world where travel may still be complicated. Certain hotels, whether its a game-changer or a grande dame, have the X-factor that inimitable quality that makes them magical, sets them apart from all the others, which has nothing to do with price.

That magic is different for everyone. It might be the art on the walls, or the stories buried within them; it might be a vibe, a setting, or a place where you can sleep deeply and awake feeling like gods. Or perhaps its just that feeling that youre home, only better.

Great hotels are not simply set in great locations, but shaped by them. The location should run right through it: in the view, of course, but also in the food, the philosophy, the architecture and design. Choose a setting that moves you, whether ocean or mountains, an empty wilderness or a city with hidden depths. Certain landscapes are imbued with a romance that can tip postnuptial happiness into vertigo: Impressionistic Provence or Tuscanys gilded hills; the timeless dolce vita of Italys Lakes or Riviera.

Islands cannot fail, with their inherent romance that comes from being cut off from the rest of the world. Go-slow Mediterranean islands, steeped in history, are bewitching for lovers: Ischia, Formentera, Hydra, Sicily, Corsica, with fingernail coves scented by wildflowers.

Then there are those private palm-fringed paradises, such as North Island Seychelles and Maldives original Gili Lankanfushi, Indonesias Bawah Reserve, or The Brando, adrift in the South Pacific. For wilder spirits, some craggy outpost, from sensational Islas Secas on Panamas Pacific coast to Eilean Shonain Scotland.

Read the original post:
The anatomy of a perfect honeymoon hotel: what to look for and what to avoid - Telegraph.co.uk

Grey’s Anatomy Coming Soon To Disney+ (UK/AU/IE/NZ) – What’s On Disney Plus

Disney+ is set to get a massive expansion on Tuesday 23rd February when the sixth brand is added called Star, which will the home to thousands of hours of movies and television from Disneys creative studios, including Disney Television Studios, FX, 20th Century Studios, 20th Television, Touchstone, and more, enhanced by the addition of local programming from the regions.

One of the biggest shows in the world is Greys Anatomy, which will be coming to Disney+ as part of the launch of Star. This show has been the recipient of the 2007 Golden Globe Award for Best Drama Television Series and nominated for multiple Emmys, including Outstanding Drama Series, Greys Anatomy is considered one of the great television shows of our time. The high-intensity medical drama, now in its 17th season, follows Meredith Grey and the team of doctors at Grey Sloan Memorial who are faced with life-or-death decisions on a daily basis. They seek comfort from one another, and, at times, more than just friendship. Together they discover that neither medicine nor relationships can be defined in black and white.

This series consists of 369 episodes, spread across seventeen seasons. There will be some regional differences in terms of how many seasons will be available. Australia and New Zealand will be getting seasons 15, 16 and 17, while the UK and Ireland will be getting seasons 1 through to 15. This is due to existing streaming contracts in these countries.

Greys Anatomy stars Ellen Pompeo as Meredith Grey, Chandra Wilson as Miranda Bailey, James Pickens Jr. as Richard Webber, Kevin McKidd as Owen Hunt, Kim Raver as Teddy Altman, Jesse Williams as Jackson Avery, Camilla Luddington as Dr. Jo, Caterina Scorsone as Amelia Shepherd, Kelly McCreary as Maggie Pierce, Giacomo Gianniotti as Andrew DeLuca, Chris Carmack as Atticus Link Lincoln, Jake Borelli as Levi Schmitt, Greg Germann as Tom Koracick, Richard Flood as Cormac Hayes and Anthony Hill as Winston Ndugu. With early episodes also starring Sandra Oh, Katherine Heigl, Justin Chambers, T. R. Knight and Patrick Dempsey.

Greys Anatomy was created and is executive produced by Shonda Rhimes (Scandal, How to Get Away with Murder, Station 19). Betsy Beers (Scandal, How to Get Away with Murder, Station 19), Mark Gordon (Saving Private Ryan), Krista Vernoff (Shameless), Debbie Allen, Zoanne Clack, Fred Einesman, Andy Reaser and Meg Marinis are executive producers. Greys Anatomy is produced by ABC Signature.

Are you looking forward to Greys Anatomy arriving on Disney+ in the UK, Europe, Australia and New Zealand.

Roger has been a Disney fan since he was a kid and this interest has grown over the years. He has visited Disney Parks around the globe and has a vast collection of Disney movies and collectibles. He is the owner of What's On Disney Plus & DisKingdom. Email: Roger@WhatsOnDisneyPlus.com Twitter: Twitter.com/RogPalmerUKFacebook: Facebook.com/rogpalmeruk

Follow this link:
Grey's Anatomy Coming Soon To Disney+ (UK/AU/IE/NZ) - What's On Disney Plus

Katherine Heigl Reveals If She Would Ever Return To Grey’s Anatomy – Nicki Swift

Katherine Heigl may have been gone fromGrey's Anatomy for over a decade, but her character Izzie Stevens is well and alive. Grey's writers brought back the original character when they wrote off Justin Chambers' character Alex Karev, who had an on-and-off relationship with her, in March 2020. In the story arc, Karev chose to relocate to Kansas and be with Stevens while raising their two kids (via The Hollywood Reporter).

While some fans were disappointed with the storyline, others were hopeful that Heigl's character being alive would mean that she'd eventually make an appearance when Grey's ends in the future an idea that Heigl isn't completely against. "I could never say never," Heigl responded when asked by The Washington Post if she'd ever return to the show that made her famous. "I think it would just be completely dependent upon the team over there, how they feel about it, and the story."

For her part, Heigl is focused on bettering herself and letting go of her bad reputation, telling The Washington Post, "I've grown into accepting that ambition is not a dirty word, and that it doesn't make me less of a feminine, loving, nurturing woman to be ambitious and have big dreams and big goals."

View original post here:
Katherine Heigl Reveals If She Would Ever Return To Grey's Anatomy - Nicki Swift